²¿·ÝÖÐÎÄ°¬Ë¾×ôÆ¥¿Ë¡´¦·½×ÊÁÏ£¨½ö¹©²Î¿¼£© Ó¢ÎÄÃû£ºEszopiclone ÉÌÆ·Ãû£ºLunesta ÖÐÎÄÃû£º°¬Ë¾×ôÆ¥¿Ë¡Ƭ Éú²úÉÌ£ºÎÀ²ÄÓÐÏÞ¹«Ë¾ Ò©Æ·¼ò½é Lunesta£¨Eszopiclone£©ÊôÓÚÒ»×é°²ÃßÒ©³ÆΪ·Ç±½¶þµª×¿ÀàÒ©ÎËüÊÇÒ»ÖÖÕò¾²´ßÃßÒ©ÎÓÃÓÚÖÎÁÆ˯ÃßÕÏ°¡£ ¥ë¥Í¥¹¥¿åV1mg/¥ë¥Í¥¹¥¿åV2mg/¥ë¥Í¥¹¥¿åV3mg Ò©Ó÷ÖÀàÃû³Æ ʧÃßÖÎÁÆ Åú×¼ÈÕÆÚ£º2012Äê4Ô É̘ËÃû Lunesta Ò»°ãÃû ¥¨¥¹¥¾¥Ô¥¯¥í¥ó£¨Eszopiclone£© »¯ ѧ Ãû £¨5S£©-6-£¨5-Chloropyridin-2-yl£©-7-oxo-6,7-dihydro-5H-pyrrolo£Û3,4-b£Ýpyrazin-5-yl 4-methylpiperazine-1-carboxylate ·Ö ×Ó Ê½ C17H17ClN6O3 ·Ö×ÓÁ¿ 388.81 ˜‹ Ôì ʽ ÎïÀí»¯Ñ§µÄÐÔ×´ °¬Ë¾×ôÆ¥¿Ë¡ÊÇ°×É«µ½µ»ÆÉ«·ÛÄ©¡£ ±¾²úÆ·ÊÇ´×ËáÑΡ¢N¡¢N-¶þ¼×»ù¼×õ£°·¡¢ËÄÇâ·úÍé»ò¶þÂȼ×Í飬²»Ò×ÈÜÓÚËÄÇâ·úÍé»ò¶þÂȼ×Íé¡¢¼×´¼¡¢ÒÒ´¼£¨99.5£©¡¢±ûͪ¡¢2-¶¡Íª¡¢ÒÒËáÒÒõ¥»ò¼×±½£¬ ºÜÄÑÈÜÓÚË®¡£ Èںϵã Ô¼ 205°C ҩЧҩÀí 1. ²Ù×÷»úÖÆ ¸ÃÖƼÁÊǵª±ûͪ£¨£¨S£©-Òì¹¹Ì壩µÄÖÖ×åÒì¹¹Ì壬ÊǾßÓÐ×ôƤ¿ËÁú´ó²¿·ÖÒ©Àí»îÐÔµÄÖƼÁ¡£ EszopiclonÓëÖÐÊàÉñ¾ÏµÍ³GABAAÊÜÌ帴ºÏÎïµÄ±½²¢¶þµªÔÓ׿½áºÏλµã½áºÏ£¬Í¨¹ý´Ù½øGABA¶ÔÂÈ»¯ÎïÀë×ÓµÄÉñ¾Ï¸°ûµÄÁ÷È룬±»ÈÏΪÄÜÔöÇ¿GABAµÄ×÷Óᣠ2. ¶¯Îï¶ÔÄԵ粨µÄÓ°Ïì Eszopilon£¬Ð¡Ê󣬴óÊóºÍëàÊó£¬Ëõ¶ÌÁË·ÇREM˯ÃßDZ·üʱ¼ä£¬ÑÓ³¤ÁË·ÇREM˯Ãßʱ¼ä¡£¶ÔREM˯ÃßûÓÐÃ÷ÏÔµÄÓ°Ïì¡£ 3. ÆäËûÖÐÐÄ×÷Óà °¬Ë¾×ôÆ¥¿Ë¡£¬Ð¡Ê󣬴óÊóºÍºï×Ó£¬±íÏÖ³ö¿¹½¹ÂǺÍÕò¾²×÷ÓᣠÊÊÓ¦Ö¢ ʧÃß Ó÷¨ÓëÓÃÁ¿ ͨ³££¬³ÉÈËÒ»´Î2ºÁ¿Ë×÷Ϊ°£Ë¹×ôƤ¿ËÁú£¬ÀÏÄêÈËÔÚ˯ǰ¿Ú·þ1ºÁ¿Ë¡£ÁíÍ⣬ËäÈ»Êʵ±Ôö¼Ó»ò¼õÉÙµÄÖ¢×´£¬ÔÚ³ÉÈËÖÐÒ»´Î3mg£¬¼Ù¶¨²»³¬¹ý2mgÔÚÀÏÄêÈËÒ»´Î¡£ °ü×° Ƭ¼Á 1ºÁ¿Ë£º100Ƭ£¨PTP ƿװ£©¡¢140Ƭ £¨PTP14Tx10£©¡¢500Ƭ£¨PTP£© 2ºÁ¿Ë£º100Ƭ£¨PTP£©¡¢140 Ƭ£¨PTP14T x 10£©¡¢500Ƭ£¨PTP ƿװ£© 3ºÁ¿Ë£º100Ƭ£¨PTP£©¡¢140 Ƭ£¨PTP14T x 10£©¡¢500Ƭ£¨Æ¿×°£© ÖÆÔìÉÌ ÎÀ²ÄÓÐÏÞ¹«Ë¾ ÌáЯ Sunovion Pharmaceuticals Inc. ×¢£ºÒÔÉÏÖÐÎÄ´¦·½×ÊÁϲ»¹»ÍêÕû£¬Ê¹ÓÃÕßÒÔÔ´¦·½Îª×¼¡£ ÍêÕû˵Ã÷×ÊÁϸ½¼þ£º https://www.info.pmda.go.jp/go/pack/1129010F1028_1_10/